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are established, the model calculates HIV incidence as well as deaths attributable to AIDS. These estimates and projections are made for the same set of 58 countries, which includes all countries with HIV prevalence above one percent as well as very populous countries with lower prevalence (China, India, the United States, the Russian Federation, and Brazil). For those 58 countries, which accounted for 93.2 percent of all AIDS deaths in 2007, information by age for different indicators and events, including deaths, is available by calendar year.
To obtain global estimates of AIDS deaths at the world and regional levels, estimates for all other countries for the period 1980-2007 produced by UNAIDS (2008) 2 were used and added to the estimates for the 58 countries. The projection of AIDS deaths at aggregated levels for the period 2008-2030 is based mainly on the 58 country-specific projections and assumes that the proportion of AIDS deaths that occurred in those countries in 2007 at the world level (that is 93.2 percent) remains constant in the future (a similar assumption is made at the regional level, though the proportion of AIDS deaths varies by region). Consequently, the projected numbers of AIDS deaths presented worldwide are based on the 58 countries adjusted by a factor of 1.073 to account for AIDS deaths in other countries.
THE EVOLUTION OF THE EPIDEMIC
HIV prevalence levels from 1975 to 2030 are plotted in Epidemics also started at different times-for example, the ones in the United States and Uganda started relatively early and the ones in the Russian Federation and South Africa relatively late. Despite these differences, the general shapes of the prevalence patterns are broadly similar. Epidemics initially spread slowly, are followed by a period of rapid expansion, and end with a plateau. In a number of countries, a significant decline started before 2007. Nearly all epidemics reached their plateau in the 1990s or the early 2000s.
The appearance of recent plateaus is one of the epidemic's most interesting and important features. A stable or declining infection level implies that the virus is present in a proportion of the population yet is not spreading any further. There are several explanations for such an unexpected development (Bongaarts et al. 2008; Potts et al. 2008; Shelton et al. 2006) .
First, high-risk behavior has declined in a number of countries, in part because of prevention programs that encourage abstinence, sexual fidelity, and condom use and that discourage needle sharing. For example, in Uganda, following a vigorous campaign that started in the late 1980s, HIV prevalence declined by about half. There is strong evidence that behavioral change contributed to this decline, and both men and women have reported a reduction in sex with non-regular partners and a rise in condom use (Stoneburner and Low-Beer 2004) . Declines in high-risk behavior and infection rates have also occurred in Kenya, Malawi, Thailand, and Zimbabwe (UNAIDS 2006 .
A second explanation for the decline in HIV prevalence is that epidemics have reached their natural limits. Every population consists of a heterogeneous mixture of subgroups with widely varying infection risks. Sex workers and their clients, needle-sharing intravenous drug users (IDUs), and homosexual men are at relatively high risk, while men and women living in monogamous unions or without sexual partners are at low risk. At the onset of an epidemic, the virus quickly invades the highest-risk groups, but then encounters resistance when the pools of high-risk and most-susceptible individuals are infected or die out.
3 The epidemic reaches a plateau when the virus has achieved maximum penetration of the vulnerable subgroups. This point seems to have been reached in most countries by the early 2000s. In the United States and Europe, for example, parts of the homosexual and IDU groups are at relatively high risk of infection, but infection risks are much lower for the vast majority of heterosexuals. As a result, HIV prevalence among heterosexuals in these regions is a fraction of one percent. In contrast, Southern African populations have relatively large high-risk groups of sex workers and their partners, and the virus spreads more readily among the general population through diffuse networks of multiple and concurrent sexual partners Epstein 2004, 2007) . The overall size of a country's epidemic depends on the sizes of the different risk groups and their behaviors (i.e. frequency of partner change, condom use), biological characteristics (e.g. male circumcision), and the prevalence of other STIs.
A third contributing factor is that the initial wave of infections in the epidemic leads about a decade later to a wave of AIDS deaths (in the absence of ART). These deaths remove infected individuals from the population (and from the numerator of the HIV prevalence rate), thus contributing to plateaus or declines in prevalence levels.
It is not possible to quantify precisely the roles of any of the factors outlined above. Behavioral change is likely to have occurred in countries where HIV prevalence is declining, but epidemics can also reach a plateau without significant behavioral change when the epidemic runs its natural course.
THE DYNAMICS OF HIV INFECTIONS AND AIDS DEATHS
The preceding analysis relied on HIV prevalence rates to assess epidemic trends. HIV prevalence is the most widely available indicator of epidemic size and it is readily interpreted. But prevalence is a lagging indicator of HIV infections. The numerator of the HIV prevalence rate consists of all currently infected adults (15-49), regardless of the time when they became infected. Because in the absence of ART individuals survive about a decade after infection, the estimated prevalence in a given year is determined by the number of infections that occurred in the past decade or earlier. The HIV incidence rate (i.e. the annual rate of new infections among adults aged 15-49) is therefore a better indicator to track epidemic trends. The total infected population at a point in time is the net result of past additions to the infected population through new infections and subtraction through deaths. The incidence rate measures the rate of new additions to the pool of infected individuals. Figure 3 presents estimates of incidence rates (solid lines) for Botswana and Uganda, two countries with large epidemics. As mentioned before, HIV incidence typically rises rapidly in the initial years of the epidemic, followed by a peak and then a large but slower decline. As expected, the peaks in incidence in Botswana (46 per 1000 per year) and Uganda (31 per 1000 per year) are more than an order of magnitude higher than the peaks in countries in other 6 continents. The timing of the peaks in incidence also varies significantly. The first occurred in the United States and in Uganda in the mid 1980s. The ongoing declines in incidence in most countries are caused by the same factors noted above for prevalence trends: saturation of highrisk groups and changes in high-risk behavior. But there is an additional third factor: a decline in the average infectiousness of infected individuals because fewer are in the acute post-infection stage and because of higher levels of ART. Note that the peaks in incidence seen in Figure 3 occurred several years before the peaks in prevalence shown in Figure 2 , Panel B.
In the absence of treatment, HIV disease runs its natural course, which means that in infected people the infection is followed by a period of years in which few symptoms are present before the onset of AIDS and then death. The distribution of the survival interval from infection to death has a mean of 11 years for males, 12 years for females, and a rather large variance. Some individuals die shortly after infection, about half die within the first 11 years, and one in four survive more than 15 years even without treatment. Figure 3 includes the estimated and projected trends in death rates because of AIDS (AIDS deaths per 1,000 population aged 15-59 as dashed lines). Note that the peaks in the death rates occur about a decade after the peaks in the incidence rates. The peaks in death rates are also lower in magnitude than the corresponding peaks in incidence rates because survival times between infection and death from AIDS vary substantially among individuals, and because treatment reduces death rates. The trajectory of the AIDS death rate in Botswana shows a sudden decline between 2003 and 2006. This decline is largely attributable to a very rapid increase in the availability and use of ART during and shortly before this period.
As expected, the AIDS death rate of a country depends on the size of the HIV epidemic. The correlation is high (R 2 =0.91), but still below one. Countries with high levels of ART (e.g. Botswana and Namibia) tend to have lower than expected death rates for a given level of prevalence because treatment suppresses the disease.
TRENDS IN AIDS MORTALITY
The UN projection model provides detailed country-level estimates of AIDS deaths and mortality rates by age and sex from 1980 to 2030 for the 58 countries for which the demographic impact of the HIV/AIDS epidemic was estimated and projected explicitly. To simplify the presentation below, only selected findings for both sexes combined are presented. Except for Figure 5 , which encompasses global estimates, all other findings are based on the estimates and projections provided by the United Nations Population Division. deaths. The initial decline in AIDS deaths starting around 2006 is partly related to the ongoing intensive global effort to provide ART to increasing proportions of AIDS patients. However, AIDS deaths subsequently rise again because of the postponement of deaths related to treatment and the occurrence of new infections; a changing population size and age distribution may also contribute to these fluctuations.
AIDS deaths
The noticeable inflection point in 2015 and the subsequent increase in the number of AIDS deaths are also partly related to assumptions made with respect to future treatment coverage levels. The proportion of the HIV-positive adult population receiving treatment in each country is consistent with estimates prepared by the World Health Organization (WHO/UNAIDS/UNICEF 2008), which averaged 36 percent in 2007 among the 58 countries, with country levels ranging from 8 percent to 99 percent. The projected coverage levels for the treatment of adults are expected to increase substantially and reach on average 64 percent for the 58 affected countries, with country levels ranging from 40 percent to 99 percent by 2015. However, coverage levels are then assumed to remain constant until 2030 at the level reached in each country in 2015. The assumptions made for treatment coverage levels as well as for other parameters in modeling the demographic impact of the 58 countries most affected by the HIV/AIDS epidemic have major bearing on the projected number of AIDS deaths at the world and regional levels.
The number of AIDS deaths varies widely by region, with the largest number in subSaharan Africa (see Panel A, Figure 5 ). In 2007 an estimated 1.5 million AIDS deaths occurred in sub-Saharan Africa, which represent 72 percent of the global total. In the rest of the world, which contains nearly 9 out of 10 of the world's people, the number of AIDS deaths is estimated at 0.6 million (mostly in Asia).
Panel B of Figure 5 plots the proportion of all deaths that are attributable to AIDS for the world, as well as for sub-Saharan Africa and Asia. For the world as a whole, this proportion peaked in 2004 at 3.9 percent. As expected, the proportion is much higher in sub-Saharan Africa (15 percent in 2004) than in the rest of the world (1.2 percent in Asia and 1.1 percent in other regions). The global proportion is expected to decline modestly to 3.3 percent by 2030.
AIDS deaths by age
AIDS deaths are concentrated among young adults and children. The reason for the large impact of the epidemic among young adults is that sexual intercourse is the dominant mode of HIV transmission. The secondary mode of transmission, from infected mother to infant around the time of birth, leads to substantial infection levels among infants, particularly in countries where fertility is high and treatment of pregnant women is lacking.
In 2007 an estimated 86 percent of AIDS deaths occurred among adults aged 15-59 in the 58 countries included in the UN projections (see Figure 6 , Panel A). In contrast, only 14 percent of AIDS deaths occurred in age group 0-14 and 0.4 percent in age group 60 and over. By 2030 only a slight change in the proportion of AIDS deaths at ages 15-59 (to 91 percent) is expected, but the proportions under age 15 and over age 60 are expected to decline and rise, respectively. Three factors are responsible for the projected decline in the proportion under age 15: a rise in 8 prevention of mother-to-child transmission of HIV (PMTCT), expanded access to ART treatment of pregnant mothers and infected children, and a decline in fertility.
The proportion of all deaths due to AIDS is much higher among adults aged 15-59 than in other age groups. As shown in Figure 6 , Panel B, this proportion reached 5.6 percent for all ages combined in 2004, but equaled 16 percent in age group 15-59, and just 3.2 percent for age group 0-14. This finding is explained by the concentration of AIDS deaths among young adults, combined with the fact that death rates from other causes are very low in this age group.
As shown in Figure 7 , the proportion of deaths due to AIDS among adults aged 15-59 has reached very high levels in a few countries in sub-Saharan Africa (e.g. 85 percent in Botswana in 2003 and 61 percent in Uganda in 1996). These two countries have very large epidemics, and by African standards they have a relatively high quality of healthcare, so that their death rates from other causes are relatively low. In contrast, in many countries outside sub-Saharan Africa, the proportion of deaths attributable to AIDS is typically well below 10 percent.
The projections to 2030 suggest that the proportion of AIDS deaths at ages 15-59 will remain approximately at current levels for the 58 countries combined (see Figure 6 , Panel B). The same is true in many individual countries, as shown in Figure 7 . The exceptions to this general trend are countries with relatively rapid declines in HIV incidence, which are expected to see future declines in proportions of deaths due to AIDS (e.g. in Uganda).
LIFE EXPECTANCY AT AGE 15
Life expectancy at age 15 (denoted e 15 ) is a widely used and easily interpretable indicator of adult mortality; it represents the average number of additional years that individuals reaching their fifteen birthday expect to live. The epidemic's impact on this indicator can be assessed by Figure 9 . According to these results, the epidemic's impact on e 15 in the non-African countries has been relatively modest-around one year or less in 2005-2010 (the large decline in e 15 in the Russian Federation between the late 1980s and the early 2000s is unrelated to the HIV/AIDS epidemic). In contrast, a much larger impact is evident in African countries. For example, in Botswana in 2000-2005 the epidemic reduced e 15 by 17.8 years, from 56.6 in the No-AIDS scenario to 38.9 years in the AIDS scenario. As previously noted, the modest rebound in e 15 in recent years in Botswana is due to the wider availability and use of ART.
As was the case for the AIDS death rate, a country's reduction in e 15 caused by AIDS mortality varies directly with the size of the HIV epidemic. Figure 10 .96) is largely due to the mortality-reducing effect of ART in countries with high ART coverage (e.g. Botswana and Namibia).
CONCLUSION
Based on our estimates, a cumulative total of 24 million people have died from AIDS between 1980 and 2007, and by 2030 this cumulative total is projected to reach 75 million. This pandemic is one of the most serious epidemics of modern times, and the eventual death toll will substantially exceed the toll from the 1918 influenza epidemic. In 2004, HIV/AIDS was the sixth leading cause of death at the world level and the fourth leading cause in low-income countries, after lower respiratory infections, ischemic heart disease, and diarrheal diseases (WHO 2008) .
Despite these grim statistics and the exceedingly rapid spread of this new disease during the 1980s and 1990s, the epidemic has reached a major turning point in recent years as the incidence of new infections peaked and began to decline. Several factors were responsible for this turnaround, including a reduction in high-risk behavior, the natural limits of the epidemic, and a decline in the infectiousness of people living with HIV. The peak in new infections is followed by a peak in death rates about a decade later because of the long average interval between infection and the onset of AIDS. Our estimates indicate that the global number of new HIV infections peaked in the mid-1990s and the number of AIDS deaths peaked at 2.16 million in 2005. Worldwide, the proportion of all deaths that are caused by AIDS reached 3.9 percent in 2004. This proportion varies widely from a high of 15 percent in sub-Saharan Africa to around one percent in Asia and other regions. In the future, the number of AIDS deaths and the proportion of deaths due to AIDS are projected to remain approximately at their current levels. Modest fluctuations may occur partly because of the rapidly spreading availability of treatment, which initially delays deaths, pushing them to later years. Fluctuations also arise because of the assumptions made with respect to future coverage levels of treatment. The size and age composition of the population are also partly responsible for the projected trends in the number of AIDS deaths.
The AIDS epidemic's impact on life expectancy at age 15 is less than a year in much of the world outside Africa but has amounted to over 10 years in Southern Africa. Projections indicate that life expectancies with AIDS will increase for nearly all countries from their current depressed levels. The impact of AIDS on e 15 is expected to remain approximately at current levels until 2030 except in a few countries (e.g. Uganda and Zimbabwe) where the epidemic is declining substantially.
These projections depend on the assumptions underlying them, and further interventions -in particular, prevention efforts-could reduce the number of AIDS deaths to lower levels. Uncertainty regarding the accuracy of the estimates of past trends in HIV prevalence, incidence, and AIDS deaths, as well as an incomplete understanding of the dynamics of the epidemic and its behavioral and biological determinants, makes any projections tentative. The difficulty of predicting future trends in behavior, prevention efforts, and affordable access to treatment must also be considered. Further research on these issues is essential to improve the accuracy of medium-term projections.
NOTES

1
HIV is the Human Immunodeficiency Virus responsible for the Acquired Immune Deficiency Syndrome (AIDS), which left untreated results in premature death.
2
For some countries and for specific periods, estimates extracted from Spectrum files were also used. For consistency purposes, slight prorating adjustments were also made when deemed necessary.
3 Assuming the presence of proper screening of blood supply and organ donors from highrisk groups to prevent non-sexual transmission to the general population through medical procedures. 
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